Author

C. A. Reis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Butsyk· 1 shared A. Diefenbach· 1 shared A. Loboda· 1 shared A. Lundquist· 1 shared A. Ohnemus· 1 shared A. Piddubnyi· 1 shared A. S. Sousa· 1 shared A. Schmidt· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Butsyk

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease

T. Boren, J. A. Bugaytsova, K. Moonens, A. Piddubnyi, A. Schmidt, J. O. Edlund, G. Lisiutin, K. Brannstrom, Y. A. Chernov, K. Thorell, I. Tkachenko, O. Sharova, I. Vikhrova, A. Butsyk, P. Shubin, , P. Aro

The paper shows that antibodies blocking H. pylori attachment reduce chronic inflammation and duodenal ulcer risk by mimicking BabA's binding to ABO glycans.

bioRxiv · May 24, 2023 · PreprintImmunology

Chitosan-olive oil microparticles for phenylethyl isothiocyanate delivery: optimal formulation

E. R. Coscueta, A. S. Sousa, C. A. Reis, M. M. Pintado

This study develops and optimizes chitosan-olive oil microparticles for PEITC delivery, achieving high entrapment efficiency and biocompatibility.

bioRxiv · Feb 24, 2021Bioengineering

Rotavirus susceptibility of antibiotic-treated mice ascribed to diminished expression of interleukin-22

D. Schnepf, P. Hernandez, T. Mahlakoiv, S. Crotta, M. E. Sullender, S. T. Peterson, A. Ohnemus, C. Michiels, I. Gentle, L. Dumoutier, C. A. Reis, A. Diefenbach, A. Wack, M. T. Baldridge, P. Staeheli

This study shows that antibiotic-treated mice are more susceptible to rotavirus due to reduced IL-22 expression, which normally inhibits viral replication through mechanisms independent of IFN signaling.

bioRxiv · Feb 18, 2021Immunology

Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology

N. B. Santos, Z. E. Vaz da Silva, C. Gomes, C. A. Reis, M. J. Amorim

This study shows that complement decay-accelerating factor (DAF) modulates influenza A virus (IAV) lung immunopathology by enhancing complement activation through interactions with viral proteins HA and NA, without affecting viral loads.

bioRxiv · Feb 16, 2021Microbiology